What people are hearing
Popular supplement claims from serious podcasts and shows, each linked to where it was said and to our grade for that exact claim.
Linking to a show is not an endorsement, by them or by us. We link so you can hear the claim in context and check it against the studies.
This grade rates the published evidence for this molecule for this use. It does not rate our product, its quality or its testing.
A low grade doesn't mean the molecule is harmful or that you should stop taking it. It means the human evidence for that use is thin. Whether to take it is your call; our job is to show you what the studies found. This is not medical advice.
What we've said: every post we have published, with sources and corrections
Glycine
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Sleep quality
Heard on: Huberman Lab, Sleep Toolkit: Tools for Optimizing Sleep & Sleep-Wake Timing: Andrew Huberman, PhD, , at 1:17:44; FoundMyFitness, How to Improve Sleep Continuity and Depth (Q&A preview): Rhonda Patrick, PhD, ; Lifespan with Dr. David Sinclair, This Sugar Substitute May Extend Your Life (S2, E9): David Sinclair, PhD, , at 1:40
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Lifespan in mice (methionine-restriction mimicry)
Heard on: Lifespan with Dr. David Sinclair, This Sugar Substitute May Extend Your Life (S2, E9): David Sinclair, PhD, , at 27:20
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Healthy aging markers with GlyNAC (glycine plus NAC)
Heard on: Lifespan with Dr. David Sinclair, This Sugar Substitute May Extend Your Life (S2, E9): David Sinclair, PhD, , at 46:08
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Collagen for skin or joints
Heard on: Lifespan with Dr. David Sinclair, This Sugar Substitute May Extend Your Life (S2, E9): David Sinclair, PhD, , at 20:16
Creatine monohydrate
Longevity and healthy aging
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Lean mass and strength in older adults, with resistance training
This is our label use; we list it for comparison.
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Bone mineral density in older adults
This is our label use; we list it for comparison.
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Memory and thinking
Heard on: FoundMyFitness, #100 The Optimal Creatine Protocol for Strength, Brain, and Longevity: Darren Candow, PhD (guest), with Rhonda Patrick, PhD, , at 35:14
- CC Small or few human trials. Promising, not proven. How we grade →
Low levels and deficiencies
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Muscle creatine stores in adults who eat little or no meat
This is our label use; we list it for comparison.
Training and performance
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →
Muscle strength and lean mass, with resistance training
Heard on: The Peter Attia Drive, #235 Training principles for mass and strength, changing views on nutrition, creatine supplementation, and more: Layne Norton, PhD (guest), with Peter Attia, MD, , at 54:30; FoundMyFitness, #100 The Optimal Creatine Protocol for Strength, Brain, and Longevity: Darren Candow, PhD (guest), with Rhonda Patrick, PhD, , at 8:36
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Mean power during repeated short sprints
This is our label use; we list it for comparison.
Specific diseases (research only)
- n/a
Depression
Heard on: FoundMyFitness, #100 The Optimal Creatine Protocol for Strength, Brain, and Longevity: Darren Candow, PhD (guest), with Rhonda Patrick, PhD, , at 53:55
Depression is a medical condition. The trials Candow describes added creatine to antidepressant treatment; none tested creatine on its own. This grades research in people with a disease. It is not a reason to buy any supplement, and it is not medical advice. Decisions about a disease belong with a clinician.
Magnesium glycinate
Longevity and healthy aging
- DD Mostly mechanistic or early data. Shown openly. How we grade →
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Relaxation and sleep quality
Heard on: Huberman Lab, Master Your Sleep & Be More Alert When Awake: Andrew Huberman, PhD, , at 1:10:00
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Blood pressure already in the normal range
This is our label use; we list it for comparison.
Low levels and deficiencies
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Omega-3 (EPA and DHA)
Longevity and healthy aging
- DD Mostly mechanistic or early data. Shown openly. How we grade →
A higher Omega-3 Index and longer life
Heard on: FoundMyFitness, #068 Dr. Bill Harris on the Omega-3 Index: Bill Harris, PhD (guest), with Rhonda Patrick, PhD, , at 54:20
- CC Small or few human trials. Promising, not proven. How we grade →
DNA methylation clocks in a post hoc analysis of adults 70 and older
This is our label use; we list it for comparison.
General health
Low levels and deficiencies
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →
Training and performance
- CC Small or few human trials. Promising, not proven. How we grade →
Daily multivitamin
Longevity and healthy aging
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Slowing memory decline in older adults
This is our label use; we list it for comparison.
Low levels and deficiencies
- CC Small or few human trials. Promising, not proven. How we grade →
Vitamin D3 (in the multivitamin)
Longevity and healthy aging
- DD Mostly mechanistic or early data. Shown openly. How we grade →
General health
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Bone health when your level is low
Heard on: FoundMyFitness, #083 How Vitamin D, Omega-3s, & Exercise May Increase Longevity: Rhonda Patrick, PhD, , at 1:10
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Normal immune function when your level is low
This is our label use; we list it for comparison.
Low levels and deficiencies
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →
Training and performance
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Muscle strength and physical performance, with no consistent gain
This is our label use; we list it for comparison.
Specific diseases (research only)
- n/a
Preventing cancer or heart disease
This is our label use; we list it for comparison.
In the VITAL trial, 2,000 IU a day for a median of 5.3 years in 25,871 adults did not lower rates of invasive cancer or major heart events. This grades research in people with a disease. It is not a reason to buy any supplement, and it is not medical advice. Decisions about a disease belong with a clinician.
Berberine HCl
General health
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Lower blood sugar in adults with high blood sugar or type 2 diabetes (the people trials studied)
Heard on: Huberman Lab, Dr. Layne Norton: The Science of Eating for Health, Fat Loss & Lean Muscle: Layne Norton, PhD (guest), with Andrew Huberman, PhD, , at 3:16:32
Nicotinamide riboside (NR)
General health
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Raising NAD+ in the blood
Heard on: Huberman Lab, Dr. Peter Attia: Supplements for Longevity & Their Efficacy: Peter Attia, MD (guest), with Andrew Huberman, PhD,
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Slowing aging or living longer
Heard on: Huberman Lab, Dr. Peter Attia: Supplements for Longevity & Their Efficacy: Peter Attia, MD (guest), with Andrew Huberman, PhD,
L-theanine
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Feeling calm and sleeping better
Heard on: Huberman Lab, Master Your Sleep & Be More Alert When Awake: Andrew Huberman, PhD, , at 1:10:00
Apigenin
General health
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Falling asleep and staying asleep
Heard on: Huberman Lab, Master Your Sleep & Be More Alert When Awake: Andrew Huberman, PhD, , at 1:10:00
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Lowering estrogen
Heard on: Huberman Lab, Master Your Sleep & Be More Alert When Awake: Andrew Huberman, PhD, , at 1:10:00
Magnesium L-threonate
General health
- CC Small or few human trials. Promising, not proven. How we grade →
Sleep and memory
Heard on: Huberman Lab, Master Your Sleep & Be More Alert When Awake: Andrew Huberman, PhD, , at 1:10:00
Whey protein
Longevity and healthy aging
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Muscle mass in older adults doing resistance training
This is our label use; we list it for comparison.
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Death rates and dietary protein in cohort studies
This is our label use; we list it for comparison.
General health
Low levels and deficiencies
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →
Reaching daily protein when intake is low
This is our label use; we list it for comparison.
Training and performance
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →
More muscle with resistance training
Heard on: Huberman Lab, Dr. Layne Norton: The Science of Eating for Health, Fat Loss & Lean Muscle: Layne Norton, PhD (guest), with Andrew Huberman, PhD,
- DD Mostly mechanistic or early data. Shown openly. How we grade →
Quoted for accuracy. No one quoted here endorses Everstack, is affiliated with us or is paid by us. A famous name never raises a grade. Grade change log · How we grade